Although dexamethasone is often used to prevent nausea and vomiting after surgery, concerns have been raised that it may increase the risk of surgical-site infection. A new study from researchers in New Zealand and Australia published on May 6 in the New England Journal of Medicine showed that dexamethasone was noninferior to placebo in the incidence of surgical-site infection within 30 days after nonurgent, noncardiac surgery.  

The Institute for Safe Medication Practices (ISMP) continues to track the errors that have been reported from the currently authorized COVID-19 vaccines.

Pregnant women should get the COVID-19 vaccine, said CDC. CDC Director Rochelle Walensky, MD, noted at a White House briefing that vaccination surveillance systems found “no safety concerns” for more than 35,000 women in their third trimester or for their babies.